Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Flora Growth Corp (FLGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/16/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2.75
1 Year Target Price $2.75
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -90.32% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.12M USD | Price to earnings Ratio - | 1Y Target Price 2.75 |
Price to earnings Ratio - | 1Y Target Price 2.75 | ||
Volume (30-day avg) 2 | Beta 2.04 | 52 Weeks Range 0.42 - 2.11 | Updated Date 07/16/2025 |
52 Weeks Range 0.42 - 2.11 | Updated Date 07/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.96 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.96% | Operating Margin (TTM) -17.76% |
Management Effectiveness
Return on Assets (TTM) -36.73% | Return on Equity (TTM) -336.65% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 19175801 | Price to Sales(TTM) 0.28 |
Enterprise Value 19175801 | Price to Sales(TTM) 0.28 | ||
Enterprise Value to Revenue 0.36 | Enterprise Value to EBITDA -1 | Shares Outstanding 22568700 | Shares Floating 19690408 |
Shares Outstanding 22568700 | Shares Floating 19690408 | ||
Percent Insiders 12.7 | Percent Institutions 3.96 |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp. was founded in 2019 and focuses on cultivating cannabis and manufacturing cannabis-derived products. It has grown through strategic acquisitions and partnerships, aiming to establish a global presence in the cannabis industry.
Core Business Areas
- Cannabis Cultivation: Flora cultivates cannabis at scale. Includes the growth, harvesting, and processing of cannabis plants to produce various cannabis products.
- Consumer Brands: Develops and markets cannabis-infused products across multiple categories, including cosmetics, food, and beverages.
- Pharmaceuticals: Focuses on the research, development, and distribution of cannabis-based pharmaceutical products.
Leadership and Structure
Luis Merchan is the CEO. The organizational structure includes divisions for cultivation, consumer brands, and pharmaceuticals.
Top Products and Market Share
Key Offerings
- Kaya Cosmetics: Cannabis-infused skincare and beauty products. Market share data is unavailable but this product line benefits from the skincare boom and wellness trends. Competitors include The Body Shop, L'Oreal, and other major beauty brands now entering the cannabis beauty market.
- Mambe Snacks: Hemp-based snacks. Market share data is unavailable but operates in the competitive health food market. Competitors include Nature Valley, KIND bars, and other snack brands.
Market Dynamics
Industry Overview
The cannabis industry is rapidly growing but faces regulatory challenges and market volatility. Increased legalization efforts and evolving consumer preferences drive demand.
Positioning
Flora Growth positions itself as a vertically integrated cannabis company with a focus on high-quality cultivation and diverse product offerings. It aims to leverage its cultivation capabilities and brand portfolio for growth.
Total Addressable Market (TAM)
The global legal cannabis market is projected to reach hundreds of billions of dollars in the coming years. Flora Growth is positioned to capture a share of this TAM through its diversified product offerings and international expansion.
Upturn SWOT Analysis
Strengths
- Vertically integrated operations
- Diverse product portfolio
- Strategic partnerships
- International presence
Weaknesses
- Limited financial resources compared to larger competitors
- Relatively new company with limited operating history
- High dependence on regulatory changes in the cannabis industry
- Low brand visibility compared to larger competitors
Opportunities
- Expansion into new markets
- Increased legalization of cannabis globally
- Growth in demand for cannabis-infused products
- Partnerships with established consumer brands
Threats
- Intense competition in the cannabis industry
- Stringent regulatory environment
- Fluctuations in cannabis prices
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- ACB
- TLRY
- CGC
Competitive Landscape
Flora Growth faces competition from larger, more established cannabis companies. Its advantages include vertical integration and a diverse product portfolio, but it needs to build brand recognition and scale operations to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Flora Growth has grown through acquisitions and expansion of its product portfolio.
Future Projections: Future growth is expected to be driven by increased legalization, expansion into new markets, and growing demand for cannabis products. Analyst estimates vary significantly due to the volatile nature of the cannabis market.
Recent Initiatives: Recent initiatives include expanding distribution channels, launching new products, and strengthening partnerships.
Summary
Flora Growth is a relatively young company in the rapidly evolving cannabis industry, leveraging vertical integration and a diversified product line. However, it faces significant competition from established players and regulatory uncertainty. Building brand visibility and securing strong financial backing will be crucial for long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website, press releases, market analysis reports, SEC filings
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. The cannabis industry is highly volatile, and investment decisions should be made with caution.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Clifford A. Starke | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com | ||
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.